Iradimed Corp (IRMD) Q3 2026 Earnings Call

Concluded Oct 30, 2026

Oct 30, 2026

Revenue $24.20M +14.2% YoY

Diluted EPS $0.51 +18.6% YoY

Gross margin 76.3% -1.5 pp YoY

Net income $6.51M +16.7% YoY

Executive readout · one minute

What the filings say

8-K earnings release · filed Oct 30, 2026: Iradimed reported record third-quarter revenue of $24.2 million and GAAP diluted EPS of $0.51. It declared a $0.20 per-share dividend payable November 27, 2026 and lowered full-year 2026 revenue guidance to $91.6 million–$93.1 million from $91.0 million–$96.0 million.
10-Q report · filed Oct 30, 2026: For the quarter ended September 30, 2026, Iradimed Corp reported revenue of $24.2 million, up 14% from $21.2 million, and net income of $6.5 million, or $0.51 per diluted share. As of September 30, 2026, cash and cash equivalents were $63.3 million.

The audio replay and transcript follow the call.

Forward guidance

7 guided metrics

Management's latest ranges and targets are included below.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Oct 30, 2026 10-Q report Filed Oct 30, 2026 Company webcastOpen the original investor-relations page

From the 8-K filed Oct 30, 2026.

Metric	Period	Guided	Basis
Revenue the fourth quarter of 2026	the fourth quarter of 2026	$25M – $26.5M	—
GAAP diluted earnings per share the fourth quarter of 2026	the fourth quarter of 2026	$0.53 – $0.57	GAAP
Non-GAAP diluted earnings per share the fourth quarter of 2026	the fourth quarter of 2026	$0.57 – $0.61	Non-GAAP
Revenue Lowered the full year 2026	the full year 2026	$91.6M – $93.1M	—
GAAP diluted earnings per share Lowered the full year 2026	the full year 2026	$1.90 – $1.94	GAAP
Stock-based compensation expense, net of tax Raised the full year	the full year	$2.5M	—
Non-GAAP diluted earnings per share Lowered the full year 2026	the full year 2026	$2.07 – $2.11	Non-GAAP

How the reported period landed and where the business moved.

Diluted EPS Within

United States$19.74M +9% YoY

Non Us$4.47M +44.7% YoY